Abstract:In transcatheter aortic valve replacement (TAVR) recipients, the optimal management of concomitant chronic obstructive coronary artery disease (CAD) remains unknown. Some advocate for pre-TAVR percutaneous coronary intervention, while others manage it expectantly. The aim of this study was to assess the impact of varying degrees and extent of untreated chronic obstructive CAD on TAVR and longer-term outcomes. The authors conducted a retrospective cohort study of TAVR recipients from January 2015 to November 2021, separating patients into stable non-obstructive or varying degrees of obstructive CAD. The major outcomes of interest were procedural all-cause mortality and complications, major adverse cardiovascular events, and post-TAVR unplanned coronary revascularization. Of the 1911 patients meeting inclusion, 75%, 6%, 10%, and 9% had non-obstructive, intermediate-risk, high-risk, and extreme-risk CAD, respectively. Procedural complication rates overall were low (death 0.4%, shock 0.1%, extracorporeal membrane oxygenation 0.1%), with no difference across groups. At a median follow-up of 21 months, rates of acute coronary syndrome and unplanned coronary revascularization were 0.7% and 0.5%, respectively, in the non-obstructive population, rising in incidence with increasing severity of CAD ( P < .001 for acute coronary syndrome/unplanned coronary revascularization). Multivariable analysis did not yield a significantly greater risk of all-cause mortality or major adverse cardiovascular events across groups. One-year acute coronary syndrome and unplanned coronary revascularization rates in time-to-event analyses were significantly greater in the non-obstructive (98%) vs. obstructive (94%) subsets ( P log-rank < .001). Transcatheter aortic valve replacement can be performed safely in patients with untreated chronic obstructive CAD, without portending higher procedural complication rates and with relatively low rates of unplanned coronary revascularization and acute coronary syndrome at 1 year. ( A ) Definitions for the four categories of coronary artery disease (CAD) studied alongside the breakdown of transcatheter aortic valve replacement (TAVR) valve type with 91% balloon-expandable valves (BEV) and 9% self-expanding valves (SEV). Procedural complication rates were minimal across the 1911 patients studied. ( B ) Cumulative incidence curve of major adverse cardiovascular events (MACE) [acute coronary syndrome (ACS), stroke, or heart failure hospitalizations] demonstrating no significant difference between obstructive and non-obstructive groups ( P = .609) ( C ) Cumulative incidence curve of unplanned coronary revascularization showing a significant difference between obstructive and non-obstructive groups ( P = .006). ( D ) Multivariable analyses for all-cause mortality and MACE. CI, confidence interval; ECMO, extracorporeal membrane oxygenation; HR, hazard ratio; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; N/A, not available; RCA, right coronary artery.

Incidence, Predictors, and Outcomes of Unplanned Coronary Angiography After Transcatheter Aortic Valve Replacement

Emergently Alteration of Procedural Strategy During Transcatheter Aortic Valve Replacement to Prevent Coronary Occlusion: A Case Report

Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement

A systematic review and meta-analysis of delayed coronary artery access for coronary angiography with or without percutaneous coronary intervention (PCI) in patients who underwent transcatheter aortic valve replacement (TAVR)

Incidence and Predictors of Permanent Pacemaker Implantation in Patients Who Underwent Transcatheter Aortic Valve Replacement: Observation of a Chinese Population.

Feasibility and Safety of Post-Transcatheter Aortic Valve Replacement Coronary Revascularization Guided by Stress Cardiac Imaging

Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement

Management and Outcome of Acute Ischemic Stroke Complicating Transcatheter Aortic Valve Replacement

National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement

Impact of previous coronary artery revascularization on outcomes in patients undergoing transcatheter aortic valve implantation

Trends in Complications among Patients undergoing Aortic Valve Replacement (AVR) in the United States

The incidence, predictors, and prognosis of acute kidney injury after transcatheter aortic valve implantation

Catastrophic Cardiac Events During Transcatheter Aortic Valve Replacement.

Outcomes of percutaneous coronary interventions after transcatheter aortic valve replacement

Cardiac computed tomography post-transcatheter aortic valve replacement

Contemporary Treatment Options for Patients Undergoing Transcatheter Aortic Valve Implantation

Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation

Survival, predictive factors, and causes of mortality following transcatheter aortic valve implantation

Evaluation and management of coronary artery disease in patients undergoing transcatheter aortic valve implantation

Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement

Incidence, characteristics, and outcome of noncardiac surgery following transcatheter aortic valve implantation